HAE|Haemonetics Corp|Price:78.650|
TradingKey provides a comprehensive stock analysis of Haemonetics Corp (HAE), highlighting its healthy fundamentals, high growth potential, and fair valuation, positioning it at 35 out of 200 in its industry. The report notes strong institutional ownership and a "Buy" rating from multiple analysts with …